Published in Eur Respir J on October 01, 1996
The antidiabetic agent glibenclamide protects airway hyperresponsiveness and inflammation in mice. Inflammation (2015) 0.75
Standardisation of spirometry. Eur Respir J (2005) 48.20
Interpretative strategies for lung function tests. Eur Respir J (2005) 21.50
General considerations for lung function testing. Eur Respir J (2005) 7.99
Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J (2005) 7.58
Standardisation of the measurement of lung volumes. Eur Respir J (2005) 7.48
Outcomes for COPD pharmacological trials: from lung function to biomarkers. Eur Respir J (2008) 5.38
Dissociation between airway inflammation and airway hyperresponsiveness in allergic asthma. Am J Respir Crit Care Med (1998) 3.22
Multicenter study of general anesthesia. III. Predictors of severe perioperative adverse outcomes. Anesthesiology (1992) 3.05
Airway smooth muscle dynamics: a common pathway of airway obstruction in asthma. Eur Respir J (2007) 2.16
Airway hyperresponsiveness in asthma: not just a matter of airway inflammation. Thorax (1998) 1.72
Coming together: the ATS/ERS consensus on clinical pulmonary function testing. Eur Respir J (2005) 1.65
Revisited role for mucus hypersecretion in the pathogenesis of COPD. Eur Respir Rev (2010) 1.48
BAL neutrophilia in asthmatic patients. A by-product of eosinophil recruitment? Chest (1996) 1.46
Usefulness of peak expiratory flow measurements: is it just a matter of instrument accuracy? Thorax (2003) 1.45
Effect of methacholine challenge on cellular composition of sputum induction. Thorax (1999) 1.45
Improved oxygenation in patients with acute respiratory failure: the prone position. Am Rev Respir Dis (1977) 1.20
Allergen-induced increase in airway responsiveness and inflammation in mild asthma. J Appl Physiol (1985) (1990) 1.16
The complete primary structure of the human snRNP E protein. Nucleic Acids Res (1988) 1.13
Evaluation of intraoperative transesophageal two-dimensional echocardiography. Anesthesiology (1987) 1.10
Halothane biotransformation in man: a quantitative study. Anesthesiology (1967) 1.10
Brainstem glioma: I. Pathology, clinical features, and therapy. J Child Neurol (1993) 1.09
Beclomethasone/formoterol in the management of COPD: a randomised controlled trial. Respir Med (2010) 1.08
Regional expiratory flow limitation studied with Technegas in asthma. J Appl Physiol (1985) (2001) 1.07
Cemented versus noncemented total hip arthroplasty--embolism, hemodynamics, and intrapulmonary shunting. Mayo Clin Proc (1992) 1.06
Assessing the reversibility of airway obstruction. Chest (1998) 1.04
On the functional consequences of bronchial basement membrane thickening. J Appl Physiol (1985) (2001) 1.04
General anesthesia and the lung. Am Rev Respir Dis (1975) 1.03
Late-phase asthmatic reaction to inhaled allergen is associated with early recruitment of eosinophils in the airways. Am Rev Respir Dis (1991) 1.02
Differential role of CD80 and CD86 on alveolar macrophages in the presentation of allergen to T lymphocytes in asthma. Clin Exp Allergy (2001) 1.02
Definition of COPD: based on evidence or opinion? Eur Respir J (2008) 1.01
Effects of deep inhalation during early and late asthmatic reactions to allergen. Am Rev Respir Dis (1990) 1.01
Physiologic approach to mechanical ventilation. Crit Care Med (1990) 1.01
Cooperation between Myc and YY1 provides novel silencing transcriptional targets of alpha3beta1-integrin in tumour cells. Oncogene (2006) 1.00
Regional intrapulmonary gas distribution in awake and anesthetized-paralyzed man. J Appl Physiol Respir Environ Exerc Physiol (1977) 1.00
Assessing the effect of deep inhalation on airway calibre: a novel approach to lung function in bronchial asthma and COPD. Eur Respir J (1998) 1.00
Geometry and respiratory displacement of human ribs. J Appl Physiol (1985) (1987) 0.99
Regional pulmonary perfusion and V/Q in awake and anesthetized-paralyzed man. J Appl Physiol Respir Environ Exerc Physiol (1977) 0.99
Severe hypoxemia and liver disease. Am Rev Respir Dis (1989) 0.98
Effects of anesthesia and muscle paralysis on respiratory mechanics in normal man. J Appl Physiol (1973) 0.97
Multicenter study of general anesthesia. II. Results. Anesthesiology (1990) 0.97
Respiratory dynamics during laughter. J Appl Physiol (1985) (2001) 0.97
Isoflurane and whole body leucine, glucose, and fatty acid metabolism in dogs. Anesthesiology (1990) 0.96
Airway responsiveness to methacholine: effects of deep inhalations and airway inflammation. J Appl Physiol (1985) (1999) 0.96
Ventilation-perfusion relationship in young healthy awake and anesthetized-paralyzed man. J Appl Physiol Respir Environ Exerc Physiol (1979) 0.94
Mechanisms for isolated volume response to a bronchodilator in patients with COPD. J Appl Physiol (1985) (2000) 0.94
Multicenter study of general anesthesia. I. Design and patient demography. Anesthesiology (1990) 0.94
Measurement of pulmonary resistance and dynamic compliance with airway obstruction. J Appl Physiol (1985) (1998) 0.93
Frequency of allergen-specific T lymphocytes in blood and bronchial response to allergen in asthma. J Allergy Clin Immunol (1993) 0.92
Expiratory flow limitation and regulation of end-expiratory lung volume during exercise. J Appl Physiol (1985) (1993) 0.91
Effect of nedocromil sodium on adenosine- and methacholine-induced bronchospasm in asthma. Clin Allergy (1987) 0.90
Dissociation between exhaled nitric oxide and hyperresponsiveness in children with mild intermittent asthma. Thorax (2000) 0.90
Effects of general anesthesia, muscle paralysis, and mechanical ventilation on pulmonary nitrogen clearance. Anesthesiology (1971) 0.90
On the causes of lung hyperinflation during bronchoconstriction. Eur Respir J (1997) 0.89
Sedation and respiratory mechanics in man. Br J Anaesth (1983) 0.89
Maximal bronchoconstriction in humans. Relationship to deep inhalation and airway sensitivity. Am J Respir Crit Care Med (1996) 0.87
Inflammatory and mechanical factors of allergen-induced bronchoconstriction in mild asthma and rhinitis. J Appl Physiol (1985) (2001) 0.87
Effects of mechanical ventilation, muscle paralysis, and posture on ventilation-perfusion relationships in anesthetized man. Anesthesiology (1973) 0.87
Increased expression of the CD80 accessory molecule by alveolar macrophages in asthmatic subjects and its functional involvement in allergen presentation to autologous TH2 lymphocytes. J Allergy Clin Immunol (1999) 0.87
Position and motion of the human diaphragm during anesthesia-paralysis. Anesthesiology (1989) 0.87
Volume quantification of chest wall motion in dogs. J Appl Physiol (1985) (1988) 0.86
Expiratory airflow limitation and hyperinflation during methacholine-induced bronchoconstriction. J Appl Physiol (1985) (1993) 0.86
Electrical activation of expiratory muscles increases with time in pentobarbital-anesthetized dogs. J Appl Physiol (1985) (1992) 0.86
Gas exchange in dogs in the prone and supine positions. J Appl Physiol (1985) (1992) 0.85
Effect of nedocromil sodium on the late asthmatic reaction to bronchial antigen challenge. J Allergy Clin Immunol (1989) 0.85
The repertoire of T-lymphocytes recovered by bronchoalveolar lavage from healthy nonsmokers. Eur Respir J (1996) 0.85
The function of each lung of anesthetized and paralyzed man during mechanical ventilation. Anesthesiology (1972) 0.85
Airway eosinophilic inflammation, epithelial damage, and bronchial hyperresponsiveness in patients with mild-moderate, stable asthma. Allergy (1996) 0.85
Rhinitis and asthma in athletes: an ARIA document in collaboration with GA2LEN. Allergy (2006) 0.84
Lung hyperinflation and flow limitation in chronic airway obstruction. Eur Respir J (1997) 0.84
Oligoclonality of lung T lymphocytes following exposure to allergen in asthma. J Immunol (1995) 0.84
Halothane, enflurane, and isoflurane depress the peripheral vagal motor pathway in isolated canine tracheal smooth muscle. Anesthesiology (1991) 0.84
Total and specific IgE in serum, bronchial lavage and bronchoalveolar lavage of asthmatic patients. Allergy (1983) 0.83
Anaesthesia and the respiratory system. Can Anaesth Soc J (1979) 0.83
Recruitment of circulating allergen-specific T lymphocytes to the lung on allergen challenge in asthma. J Allergy Clin Immunol (1997) 0.83
Time course and calcium dependence of sustained bronchoconstriction induced by deep inhalation in asthma. Am Rev Respir Dis (1991) 0.83
Effects of aerosol methacholine and histamine on airways and lung parenchyma in healthy humans. J Appl Physiol (1985) (1993) 0.83
Differences in regional vascular conductances in isolated dog lungs. J Appl Physiol (1985) (1986) 0.83
Lung recoil and gas trapping during oxygen breathing at low lung volumes. J Appl Physiol Respir Environ Exerc Physiol (1977) 0.83
Increased numbers of mast cells in bronchial mucosa after the late-phase asthmatic response to allergen. Am Rev Respir Dis (1991) 0.83
Airway inflammation and occurrence of delayed bronchoconstriction in exercise-induced asthma. Am Rev Respir Dis (1992) 0.83
Antiinflammatory-antioxidant treatment with a methane sulfonanilide in allergen-induced asthma. Ann Allergy (1991) 0.82
Intrapulmonary gas transport and perfusion during high-frequency oscillation. J Appl Physiol Respir Environ Exerc Physiol (1981) 0.82
Dose-response study of a new oral bronchodilator, NAB 365 (clenbuterol). Int J Clin Pharmacol Biopharm (1978) 0.82
Health outcomes following treatment for 6 months with once daily tiotropium compared with twice daily salmeterol in patients with COPD. Thorax (2006) 0.82
Two doses of oral ketamine, given with midazolam, for premedication in children. Minerva Anestesiol (2002) 0.82
Bronchial responsiveness is not increased by bronchoalveolar and bronchial lavage performed after allergen challenge. Am Rev Respir Dis (1991) 0.82
Changes in residual volume during induced bronchoconstriction in healthy and asthmatic subjects. Am J Respir Crit Care Med (1994) 0.82
Comparison of oral bambuterol and inhaled salmeterol in patients with symptomatic asthma and using inhaled corticosteroids. Am J Respir Crit Care Med (1999) 0.81